Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC M&A Activity 2021

Jan 26, 2021

5250_rns_2021-01-26_c661acde-5441-4f3b-b1bc-41928b3b5c1a.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

Ap19

FORM 8.3 Amendment to Purchase & Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 20 January 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,522,163 1.96% 598,821 0.46%
(2) Derivatives (other than options):
272,825 0.21% 445,393 0.35%
(3) Options and agreements to
purchase/sell: 6,000 0.00% 6,000 0.00%
TOTAL:
2,800,988 2.17% 1,050,214 0.81%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 209.3200 USD
Purchase 1 210.4150 USD
Purchase 1 209.2000 USD
Purchase 2 210.7550 USD
Purchase 2 210.4700 USD
Purchase 2 208.0400 USD
Purchase 6 210.6100 USD
Purchase 19 207.8636 USD
Purchase 45 207.7800 USD
Purchase 56 210.2732 USD
Purchase 69 209.7746 USD
Purchase 100 210.3700 USD
Purchase 200 208.8400 USD
Purchase 340 209.4160 USD
Purchase 400 209.7200 USD
Purchase 484 209.4766 USD
Purchase 728 209.9784 USD
Purchase 783 209.8657 USD
Purchase 982 209.6317 USD
Purchase 1,075 209.5881 USD
Purchase 1,285 209.5649 USD
Purchase 1,469 209.6580 USD
Purchase 1,562 209.4462 USD
Purchase 1,611 209.6413 USD
Purchase 1,976 209.5425 USD
Purchase 7,002 209.4200 USD
Purchase 7,564 210.2397 USD
Purchase 7,915 209.9274 USD
Purchase 9,482 209.5144 USD
Purchase 10,533 209.5897 USD
Purchase 10,736 210.2700 USD
Purchase 19,658 209.5539 USD
Purchase 19,839 209.7013 USD
Purchase 22,704 209.5922 USD
Sale 1 208.3500 USD
Sale 2 207.6400 USD
Sale 2 208.0400 USD
Sale 2 208.2400 USD
Sale 2 208.0900 USD
Sale 3 206.6500 USD
Sale 5 209.1000 USD
Sale 6 208.8066 USD
Sale 9 208.1600 USD
Sale 10 210.2660 USD
Sale 10 207.7400 USD
Sale 25 210.3700 USD
Sale 53 210.1760 USD
Sale 61 210.2581 USD
Sale 100 210.5600 USD
Sale 100 210.7200 USD
Sale 100 210.4100 USD
Sale 100 209.6750 USD
Sale 145 208.5110 USD
Sale 233 209.2448 USD
Sale 285 210.5270 USD
Sale 503 209.2998 USD
Sale 599 210.0147 USD
Sale 600 209.7266 USD
Sale 660 210.3004 USD
Sale 1,462 209.4305 USD
Sale 1,611 209.6413 USD
Sale 5,638 209.8466 USD
Sale 7,464 210.2585 USD
Sale 8,980 210.2700 USD
Sale 9,319 209.5224 USD
Sale 21,224 209.5596 USD
Sale 67,800 209.6135 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 26 Jan 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210126005480/en/

BARCLAYS PLC